← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Owner-earnings 10-yr IRR 10–30 points over Treasuries, yield ≤ 25% · bought the day of the annual report, held 12 months
Could be luck Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +2.9 pts (823 entries, 255 companies, could be luck). 47% of entries beat the S&P; 18% beat it by 30 points or more; 27% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +1.2 pts.
+2.9 ptsvs S&P, average
47%beat the S&P
18%up 30+ pts vs S&P
27%down 20+ pts vs S&P
+6.0 ptsvs small caps, 12 mo
−14.6 pts 2024worst year to buy ?
1.8luck check ?
Does the holding period matter?3 mo: −0.5 pts 47% beat6 mo: +0.1 pts 45% beat12 mo: +2.9 pts 47% beat24 mo: +3.3 pts 42% beat3 yr, per yr: −0.9 pts 39% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today686+1.9 pts t 1.2+5.3 pts
Sell-off (S&P ≥10% off high)137+7.9 pts t 1.4+9.6 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing255+0.9 pts t 0.4−5.1 pts
Retail & consumer106+10.5 pts t 1.9+1.9 pts
Services79−3.2 pts t -0.5−1.9 pts
Energy69+3.1 pts t 0.5−4.9 pts
Other61−4.4 pts t -0.8−3.3 pts
Tech hardware & semis58−2.8 pts t -0.6−1.4 pts
Finance & real estate46+5.9 pts t 1.5+6.8 pts
Biotech & pharma28−5.0 pts t -0.7−4.3 pts

Holds up out of sample? Before 2018: +5.1 pts (n 291, t 2.3). From 2018: +1.7 pts (n 532, t 0.8). Same sign in both halves.

Year201120122013201420152016201720182019202020212022202320242025
vs S&P−11 pts+5 pts+6 pts−5 pts−4 pts+17 pts+8 pts−10 pts−14 pts+46 pts+8 pts+8 pts−14 pts−15 pts+3 pts
n12943515669425362725676876957

Read the research behind this screen: Ranking companies as equity bonds: the top fifth beats the bottom fifth by a wide margin → · Test your own combination in the Screen Lab →

Same definitions as the table: coupon = 3-yr average owner earnings, growth capped, 15× exit. Historical IRR uses a 5-yr revenue CAGR as the growth proxy where the DCF rate is not available point-in-time. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

CLNN
Clene Inc.
Below Treasuries
Healthcare Risk 62 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +100.5%/yr vs model +2.0% · above model
CLOV
CLOVER HEALTH INVESTMENTS, CORP. /DE
Below Treasuries
Financial Services Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CLPT
ClearPoint Neuro, Inc.
Below Treasuries
Healthcare Risk 57 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +45.5%/yr vs model +22.7% · above model
CLRB
Cellectar Biosciences, Inc.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CLRO
CLEARONE INC
Below Treasuries
Technology Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -18.3%/yr vs model +15.0% · below model
CLWT
EURO TECH HOLDINGS CO LTD
Below Treasuries
Industrials Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +37.9%/yr vs model +2.0% · above model
CLYM
Climb Bio, Inc.
Below Treasuries
Healthcare Risk 30 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CM
CANADIAN IMPERIAL BANK OF COMMERCE /CAN/
Below Treasuries
Financial Services Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CMBT
CMB.TECH NV
Below Treasuries
Industrials Risk 26 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CMCL
Caledonia Mining Corp Plc
Below Treasuries
Basic Materials Risk 57 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CMCM
Cheetah Mobile Inc.
Below Treasuries
Technology Risk 54 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +50.2%/yr vs model +7.5% · above model
CMII
Columbus Circle Capital Corp II
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CMMB
Chemomab Therapeutics Ltd.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CMND
Clearmind Medicine Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CMPS
COMPASS Pathways plc
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CMPX
Compass Therapeutics, Inc.
Below Treasuries
Healthcare Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +82.9%/yr vs model +15.0% · above model
CMTG
Claros Mortgage Trust, Inc.
Below Treasuries
Real Estate Risk 67 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +27.1%/yr vs model +2.0% · above model
CMU
MFS HIGH YIELD MUNICIPAL TRUST
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNCK
Coincheck Group N.V.
Below Treasuries
Financial Services Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNF
CNFinance Holdings Ltd.
Below Treasuries
Financial Services Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNI
CANADIAN NATIONAL RAILWAY CO
Below Treasuries
Industrials Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNL
Collective Mining Ltd.
Below Treasuries
Basic Materials Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNQ
CANADIAN NATURAL RESOURCES LTD
Below Treasuries
Energy Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNS
COHEN & STEERS, INC.
Below Treasuries
Financial Services Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +38.5%/yr vs model +2.0% · above model
CNSP
CNS Pharmaceuticals, Inc.
Below Treasuries
Healthcare Risk 28 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNTA
Centessa Pharmaceuticals plc
Below Treasuries
Healthcare Risk 30 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +83.7%/yr vs model +15.0% · above model
CNTB
Connect Biopharma Holdings Ltd
Below Treasuries
Healthcare Risk 30 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +63.9%/yr vs model +15.0% · above model
CNTN
Canton Strategic Holdings, Inc.
Below Treasuries
Healthcare Risk 44 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNTX
Context Therapeutics Inc.
Below Treasuries
Healthcare Risk 31 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CNXU
Conexeu Sciences Inc.
Below Treasuries
Healthcare Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COAG
Hemab Therapeutics Holdings, Inc.
Below Treasuries
Healthcare Risk 51 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COCH
Envoy Medical, Inc.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +46.9%/yr vs model +15.0% · above model
COCP
Cocrystal Pharma, Inc.
Below Treasuries
Healthcare Risk 27 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CODX
Co-Diagnostics, Inc.
Below Treasuries
Healthcare Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +36.5%/yr vs model +2.0% · above model
COE
51Talk Online Education Group
Below Treasuries
Consumer Defensive Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +16.1%/yr vs model +50.0% · below model
COF
CAPITAL ONE FINANCIAL CORP
Below Treasuries
Financial Services Risk 55 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COGT
Cogent Biosciences, Inc.
Below Treasuries
Healthcare Risk 49 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COHR
COHERENT CORP.
Below Treasuries
Healthcare Risk 50 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +30.1%/yr vs model +17.0% · above model
COHU
COHU INC
Below Treasuries
Healthcare Risk 62 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +36.6%/yr vs model +2.0% · above model
COKE
Coca-Cola Consolidated, Inc.
Below Treasuries
Consumer Defensive Risk 58 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COLA
Columbus Acquisition Corp/Cayman Islands
Below Treasuries
Financial Services Risk 26 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COLAR
Columbus Acquisition Corp/Cayman Islands
Below Treasuries
Financial Services Risk 42 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COOK
Traeger, Inc.
Below Treasuries
Technology Risk 72 · High
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +44.0%/yr vs model +2.0% · above model
COOT
Australian Oilseeds Holdings Ltd
Below Treasuries
Consumer Defensive Risk 43 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
COPL
Copley Acquisition Corp
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CORN
Teucrium Commodity Trust
Below Treasuries
Financial Services Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CORZ
Core Scientific, Inc./tx
Below Treasuries
Financial Services Risk 34 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +49.4%/yr vs model +2.0% · above model
CORZZ
Core Scientific, Inc./tx
Below Treasuries
Financial Services Risk 26 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +140.5%/yr vs model +2.0% · above model
COYA
Coya Therapeutics, Inc.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +21.5%/yr vs model +15.0% · above model
CP
CANADIAN PACIFIC KANSAS CITY LTD/CN
Below Treasuries
Industrials Risk 33 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CPA
Copa Holdings, S.A.
Below Treasuries
Industrials Risk 36 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CPAC
CEMENTOS PACASMAYO SAA
Below Treasuries
Industrials Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CPER
United States Commodity Index Funds Trust
Below Treasuries
Financial Services Risk 32 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CPHI
CHINA PHARMA HOLDINGS, INC.
Below Treasuries
Healthcare Risk 37 · Moderate
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -2.7%/yr vs model +2.0% · below model
CPSH
CPS TECHNOLOGIES CORP/DE/
Below Treasuries
Industrials Risk 40 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies +17.0%/yr vs model +9.8% · above model
CPSS
CONSUMER PORTFOLIO SERVICES, INC.
Below Treasuries
Financial Services Risk 45 · Elevated
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
Market implies -48.5%/yr vs model +13.1% · below model
CPZ
Calamos Long/Short Equity & Dynamic Income Trust
Below Treasuries
Unknown
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRAC
Crown Reserve Acquisition Corp. I
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRACR
Crown Reserve Acquisition Corp. I
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —
CRAN
Crane Harbor Acquisition Corp. II
Below Treasuries
Financial Services
Yield0.0%
Growth used0.0%
10-yr IRR0.0%
· 0 yrs positive P/IV —